Bangchuan Hu

1.0k total citations
50 papers, 718 citations indexed

About

Bangchuan Hu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Bangchuan Hu has authored 50 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Bangchuan Hu's work include Acute Kidney Injury Research (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Clinical Nutrition and Gastroenterology (4 papers). Bangchuan Hu is often cited by papers focused on Acute Kidney Injury Research (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Clinical Nutrition and Gastroenterology (4 papers). Bangchuan Hu collaborates with scholars based in China and United States. Bangchuan Hu's co-authors include Ren-Hua Sun, Jingquan Liu, Minhua Chen, Ziqiang Shao, Run Zhang, Liang Xu, Ji‐Guang Wang, Yang Zheng, Shi‐Jing Mo and Jun Hong and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Microbiology.

In The Last Decade

Bangchuan Hu

47 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bangchuan Hu China 16 179 139 135 101 91 50 718
Akanksha Gupta United States 16 223 1.2× 152 1.1× 137 1.0× 44 0.4× 50 0.5× 32 766
Barbara Adamik Poland 18 198 1.1× 243 1.7× 86 0.6× 90 0.9× 98 1.1× 60 803
Roy D. Goldfarb United States 15 117 0.7× 297 2.1× 112 0.8× 52 0.5× 99 1.1× 39 778
Dany Mercan Belgium 8 101 0.6× 305 2.2× 67 0.5× 99 1.0× 97 1.1× 16 664
Carlo Chiarla Italy 19 116 0.6× 186 1.3× 67 0.5× 145 1.4× 176 1.9× 58 854
Patrick Lahni United States 20 272 1.5× 511 3.7× 93 0.7× 69 0.7× 157 1.7× 51 1.1k
Michiel E. Stegenga Netherlands 10 103 0.6× 308 2.2× 122 0.9× 26 0.3× 88 1.0× 11 802
Gordon P Otto Germany 12 200 1.1× 362 2.6× 86 0.6× 27 0.3× 86 0.9× 20 934
John Constant United States 5 191 1.1× 469 3.4× 59 0.4× 50 0.5× 154 1.7× 10 951
Milan Dastych Czechia 12 89 0.5× 81 0.6× 91 0.7× 69 0.7× 49 0.5× 52 445

Countries citing papers authored by Bangchuan Hu

Since Specialization
Citations

This map shows the geographic impact of Bangchuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bangchuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bangchuan Hu more than expected).

Fields of papers citing papers by Bangchuan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bangchuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bangchuan Hu. The network helps show where Bangchuan Hu may publish in the future.

Co-authorship network of co-authors of Bangchuan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Bangchuan Hu. A scholar is included among the top collaborators of Bangchuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bangchuan Hu. Bangchuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Jie, Guohua Wu, Di Wu, et al.. (2025). Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity. Lab on a Chip. 25(12). 2839–2850. 9 indexed citations
3.
Yu, Jia, Junhua Li, Bangchuan Hu, et al.. (2024). Targeting SLC22A5 fosters mitophagy inhibition-mediated macrophage immunity against septic acute kidney injury upon CD47-SIRPα axis blockade. Heliyon. 10(7). e26791–e26791. 1 indexed citations
4.
Yang, Zheng, Xue Yang, Ziqiang Shao, et al.. (2023). Alcohol dehydrogenase 1 is a tubular mitophagy-dependent apoptosis inhibitor against septic acute kidney injury. Experimental Cell Research. 433(1). 113804–113804. 6 indexed citations
5.
6.
Chen, Zhidong, Bangchuan Hu, Jun Hong, et al.. (2021). Ascorbate uptake enables tubular mitophagy to prevent septic AKI by PINK1-PARK2 axis. Biochemical and Biophysical Research Communications. 554. 158–165. 15 indexed citations
8.
Hu, Bangchuan, Guohua Wu, Ziqiang Shao, et al.. (2020). Redox DAPK1 destabilizes Pellino1 to govern inflammation-coupling tubular damage during septic AKI. Theranostics. 10(25). 11479–11496. 20 indexed citations
10.
Xu, Liang, Weijun Zhang, Ren-Hua Sun, et al.. (2017). IGF-1 may predict the severity and outcome of patients with sepsis and be associated with microRNA-1 level changes. Experimental and Therapeutic Medicine. 14(1). 797–804. 17 indexed citations
11.
Chen, Minhua, et al.. (2016). [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].. PubMed. 28(3). 246–51. 1 indexed citations
12.
Liu, Jingquan, Kai Shi, Minhua Chen, et al.. (2015). Elevated miR-155 expression induces immunosuppression via CD39 + regulatory T-cells in sepsis patient. International Journal of Infectious Diseases. 40. 135–141. 50 indexed citations
13.
Li, Lihua, Chang‐Sheng Sheng, Bangchuan Hu, et al.. (2015). The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study. BMC Cardiovascular Disorders. 15(1). 31–31. 37 indexed citations
14.
Ma, Leilei, Fei‐Juan Kong, Hongwei Ge, et al.. (2014). Ventricular hypertrophy blocked delayed anesthetic cardioprotection in rats by alteration of iNOS/COX-2 signaling. Scientific Reports. 4(1). 7071–7071. 7 indexed citations
15.
Ma, Leilei, Hongwei Ge, Fei‐Juan Kong, et al.. (2014). Ventricular Hypertrophy Abrogates Intralipid-Induced Cardioprotection by Alteration of Reperfusion Injury Salvage Kinase/Glycogen Synthase Kinase 3β Signal. Shock. 41(5). 435–442. 8 indexed citations
16.
Li, Li, et al.. (2013). Role of mitochondrial damage during cardiac apoptosis in septic rats. Chinese Medical Journal. 126(10). 1860–1866. 21 indexed citations
17.
Hu, Bangchuan, Yan Li, Ming Liu, Chang‐Sheng Sheng, & Ji‐Guang Wang. (2013). Ankle–brachial index in relation to the natriuretic peptide system polymorphisms and urinary sodium excretion in Chinese. Atherosclerosis. 230(1). 86–91. 4 indexed citations
18.
Hu, Bangchuan, et al.. (2010). Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese. Journal of Hypertension. 29(3). 501–508. 11 indexed citations
19.
Hu, Bangchuan, Shaoli Chu, Guliang Wang, et al.. (2008). Association between Genetic Variation in Transforming Growth Factors β1 and β3 and Renal Dysfunction in Non-Diabetic Chinese. Clinical and Experimental Hypertension. 30(2). 121–131. 7 indexed citations
20.
Hu, Bangchuan, et al.. (2006). [Single nucleotide polymorphisms of three candidate genes in essential hypertension].. PubMed. 45(4). 281–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026